https://www.thebodypro.com/author/calvin-cohen

Latest by Calvin Cohen, M.D., M.S.

Promo Image

Tenofovir DF: A 24-Week Interim Analysis From a Phase III Double-Blind, Placebo-Controlled Study in Antiretroviral-Experienced Patients

Tenofovir DF: A 24-Week Interim Analysis from a Phase III Double-Blind, Placebo-Controlled Study in Antiretroviral-Experienced Patients Abstract 666 Authored by K. Squires (Univ. Southern California, Los Angeles, CA), G. Pierone (Treasure C...

Promo Image

Use of Structured Treatment Interruptions in Primary Infections

Use of Structured Treatment Interruptions in Primary Infections Abstract 421 Authored by Philippe Hermans (CHU Saint-Pierre Hosp., Brussels, Belgium) View the original abstract

This talk reviewed the potential to "autovaccinate" those ...

Promo Image

The Next Target in Therapy: Viral Entry

To view a video of this presentation, click here Please note: Best viewed with Internet Explorer.(Requires Real Player for Windows or Macintosh)

The Next Target in Therapy: Viral Entry (Abstract PL9) Speaker: E. Hunter Authored by Hunter, E....

Promo Image

New Antiretrovirals Host Immunology, Pathogenesis and Dynamics Mechanisms of HIV-Drug Resistance Drug Resistance, Exposure and Treatment Response Genotype/Phenotype Relationship, Modelling and Algorithms

To view a video of this presentation, click here Please note: Best viewed with Internet Explorer.(Requires Real Player for Windows or Macintosh)

New Antiretrovirals Host Immunology, Pathogenesis and Dynamics Mechanisms of HIV-Drug Resistance Drug Re...

Promo Image

Low-Level HIV Viral Rebound and Blips in Patients Receiving Potent Antiretroviral Therapy

Low-Level HIV Viral Rebound and Blips in Patients Receiving Potent Antiretroviral Therapy (Slide Session 522) Authored by G. Greub, A. Cozzi Lepri, B. Ledergerber, S. Staszewski, L. Perrin, V. Miller, P. Francioli, H. Furrer, M. Battegay, P. Ve...

Promo Image

The Effect of Treatment Interruption in Patients With Virologic Failure: Results From a Multi-Cohort Collaborative Study

The Effect of Treatment Interruption in Patients with Virologic Failure: Results from a Multi-Cohort Collaborative Study (Poster 365) Authored by Sabin, A. Phillips, J. Fusco, M. Youle, J. Gill, J. Barbour, A. D'Arminio Monforte, B. Dauer, S. S...

Promo Image

Continued Low Mortality and Morbidity, and HAART Utilization among HIV-Infected Patients in the HIV Outpatient Study (HOPS)

Continued Low Mortality and Morbidity, and HAART Utilization among HIV-Infected Patients in the HIV Outpatient Study (HOPS) (Slide Session 268B) Authored by F. Palella, J. Chmiel, M. Deloria-Knoll, A. Moorman, S. Holmberg, and the HOPS Investig...

Promo Image

Viral Reservoirs and Ongoing Virus Replication in Patients on HAART: Implications for Clinical Management)

Viral Reservoirs and Ongoing Virus Replication in Patients on HAART: Implications for Clinical Management (State-of-the-Art Lecture L5) Authored by Robert SilicianoView the original abstract

For the past several years, there has been hope that...

Promo Image

Prospective, Randomized, Controlled Phase II Study of Highly Active Antiretroviral Therapy (HAART) with Continuous IV (CIV) or Subcutaneous (SC) Interleukin-2 (IL-2) in HIV-Infected Patients with CD4+Counts of 50 -- 350 cells/mm3: ACTG 328 -- Final Result

Prospective, Randomized, Controlled Phase II Study of Highly Active Antiretroviral Therapy (HAART) with Continuous IV (CIV) or Subcutaneous (SC) Interleukin-2 (IL-2) in HIV-Infected Patients with CD4+Counts of 50 -- 350 cells/mm3: ACTG 328 -- Final...